SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARZOLA, Giuliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.635
AS - Asia 1.240
EU - Europa 967
SA - Sud America 154
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 5
Totale 5.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.572
SG - Singapore 440
CN - Cina 358
DE - Germania 334
FI - Finlandia 165
VN - Vietnam 148
BR - Brasile 118
IT - Italia 107
UA - Ucraina 105
GB - Regno Unito 99
HK - Hong Kong 68
TR - Turchia 62
BD - Bangladesh 47
FR - Francia 46
CA - Canada 39
SE - Svezia 30
IN - India 27
JP - Giappone 22
RU - Federazione Russa 20
MX - Messico 15
PL - Polonia 13
IQ - Iraq 10
ES - Italia 9
LT - Lituania 9
NL - Olanda 9
PK - Pakistan 9
UZ - Uzbekistan 9
AR - Argentina 8
ID - Indonesia 8
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
AU - Australia 5
EG - Egitto 5
IL - Israele 5
PY - Paraguay 5
CO - Colombia 4
MA - Marocco 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
BE - Belgio 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BY - Bielorussia 1
EE - Estonia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MQ - Martinica 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 5.029
Salva come PNG Salva come JPEG
Città #
Ashburn 338
Singapore 276
Munich 250
Fairfield 226
Woodbridge 214
Houston 173
San Jose 139
Beijing 123
Jacksonville 117
Helsinki 108
Chandler 95
Ann Arbor 94
Santa Clara 94
Seattle 88
Wilmington 84
Cambridge 78
Hong Kong 66
New York 66
Dallas 62
Ho Chi Minh City 49
Los Angeles 45
Nanjing 34
Hanoi 31
Izmir 29
Shanghai 28
San Diego 26
Turku 26
Boardman 25
Milan 24
Princeton 24
Orem 22
Tokyo 21
Frankfurt am Main 18
São Paulo 18
Lauterbourg 17
Ferrara 16
The Dalles 16
Council Bluffs 15
London 13
Mcallen 13
Buffalo 12
Montréal 12
Bremen 11
Chennai 11
Denver 11
Montreal 11
Chicago 10
Haiphong 10
Mexico City 10
Atlanta 9
Dearborn 9
Poplar 9
Rome 9
Stockholm 9
Tianjin 9
Guangzhou 8
Hebei 8
Nanchang 8
Shenyang 8
Tashkent 8
Toronto 8
Warsaw 8
Brooklyn 7
Da Nang 7
Falkenstein 7
Hefei 7
Manchester 7
Amsterdam 6
Dhaka 6
Falls Church 6
Jyväskylä 6
Washington 6
Addison 5
Baghdad 5
Bexley 5
Bologna 5
Changsha 5
Johannesburg 5
Mountain View 5
Norwalk 5
Philadelphia 5
Rio de Janeiro 5
San Mateo 5
Sydney 5
Tappahannock 5
Indiana 4
Jiaxing 4
Naples 4
Newark 4
Phoenix 4
San Francisco 4
Ardabil 3
Asunción 3
Auburn Hills 3
Barnet 3
Boston 3
Brasília 3
Brussels 3
Bến Tre 3
Caracas 3
Totale 3.590
Salva come PNG Salva come JPEG
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 406
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 319
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 276
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 272
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 266
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 261
Post-ischemic recovery of acetylcholine release in vitro: influence of different excitatory amino acid receptor subtype antagonists 258
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 256
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 254
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 236
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 230
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 229
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 228
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 218
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 205
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 202
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 202
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 198
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 196
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 171
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 117
null 50
Totale 5.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.380
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022281 6 31 33 17 18 13 12 20 9 26 25 71
2022/2023232 21 18 21 31 37 26 17 14 27 1 9 10
2023/2024183 14 15 11 7 9 58 8 13 4 1 8 35
2024/2025901 7 14 44 39 74 119 106 80 167 46 97 108
2025/20261.865 203 67 143 264 258 130 209 91 175 177 123 25
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 5.050